There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Molecular testing at the point-of-care may turn out to be game changer for HCV diagnosis
and treatment monitoring, through increased sensitivity, reduced turnaround time,
and ease of performance. One such assay GeneXpert® has recently been released.